Patent ID: 9422606
Filing Date: 2016-08-23
CPC Classification: C12Q

Claim Text:
1. A method of detecting the presence of a gIVS6a+415_IVS10+2987Dup26817bp mutation in the cystic fibrosis transmembrane regulatory (CFTR) gene in a human individual comprising: (a) amplifying a nucleic acid molecule comprising the sequence of SEQ ID NO: 2 from a nucleic acid sample obtained from the human individual using: (b) detecting the amplified nucleic acid molecule, if present, thereby detecting the gIVS6a+415_IVS10+2987Dup26817bp mutation, wherein detecting the amplified nucleic acid comprising the sequence of SEQ ID NO: 2 indicates the presence of the gIVS6a+415_IVS10+2987Dup26817bp mutation.